SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis
SARS-CoV-2 예방 접종은 CD8 T 세포 우성 간염을 유발할 수 있습니다
Case Reports
Published on
Journal: Journal of hepatology [Category] A형 간염, COVID19(2023년), Fulltext, MERS, SARS, 진단,
Journal: Journal of hepatology [Category] A형 간염, COVID19(2023년), Fulltext, MERS, SARS, 진단,
[키워드] accumulate
activated
activated T cell
antibody
Autoimmune
Autoimmune hepatitis
B cells
bimodal
BNT162b2 mRNA vaccination
CD4 T cells
CD8 T cell
CD8 T-cell
CD8+
CD8+ T cell
Cell
contribute
controls
correlated
COVID-19
COVID-19 vaccination
Cytometry
described
dissect
distribution
dominant
elicit
ELISA
feature
Flow
Hepatitis
identify
imaging
immune
immune correlates
immune profiling
Immune-mediated
Immunity
immunoglobulins
Immunosuppression
individual
Inflammation
intrahepatic
Laboratory results
liver
Liver disease
male
myeloid cell
occur
pathophysiology
Patient
Peripheral blood
phenotype
Plasma cell
presenting
reactive
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccination
severity
systemic steroids
T cell
T cells
tissue
unique
vaccination
virus-specific T cell
was performed
[DOI] 10.1016/j.jhep.2022.03.040 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1016/j.jhep.2022.03.040 PMC 바로가기 [Article Type] Case Reports